Aspirin-triggered proresolving mediators stimulate resolution in cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin-triggered proresolving mediators stimulate resolution in cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 13, Pages 6292-6297
Publisher
Proceedings of the National Academy of Sciences
Online
2019-03-13
DOI
10.1073/pnas.1804000116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
- (2018) Jaimie Chang et al. FASEB JOURNAL
- Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
- (2018) Peter M Rothwell et al. LANCET
- Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma
- (2018) Yi Ye et al. NEUROPHARMACOLOGY
- Splenic leukocytes define the resolution of inflammation in heart failure
- (2018) Ganesh V. Halade et al. Science Signaling
- Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity
- (2018) Oliver Werz et al. Nature Communications
- Splenic leukocytes define the resolution of inflammation in heart failure
- (2018) Ganesh V. Halade et al. Science Signaling
- Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
- (2017) Hernan Roca et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolvins suppress tumor growth and enhance cancer therapy
- (2017) Megan L. Sulciner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
- (2017) Nella Prevete et al. OncoImmunology
- Lipoxin A4selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression
- (2016) R. L. Simões et al. INTERNATIONAL JOURNAL OF CANCER
- Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
- (2016) Hildur H. Arnardottir et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
- (2016) Asad Umar et al. SEMINARS IN ONCOLOGY
- Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells
- (2016) Paloma Guillem-Llobat et al. Oncotarget
- Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
- (2015) Angelo Restivo et al. BRITISH JOURNAL OF CANCER
- Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity
- (2015) HAOYU KUANG et al. ONCOLOGY REPORTS
- Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production
- (2015) Ramesh C. Halder et al. Frontiers in Physiology
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma
- (2013) Lena-Maria Carlson et al. CARCINOGENESIS
- Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
- (2013) Jesmond Dalli et al. CHEMISTRY & BIOLOGY
- Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
- (2013) Hye Ja Lee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial
- (2013) S Marlene Grenon et al. VASCULAR MEDICINE
- Breast Cancer Risk Reduction: No Pain, No Gain?
- (2012) Clifford A. Hudis et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
- (2012) Shan Hu et al. Journal of Neuroinflammation
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
- (2011) Dipak Panigrahy et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk
- (2010) C. A. Salinas et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Aspirin and non-small cell lung cancer resections: effect on long-term survival☆
- (2010) Eustace Fontaine et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
- (2010) Neil Dufton et al. JOURNAL OF IMMUNOLOGY
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways
- (2010) T. Morris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started